公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2019 | Taiwan consensus statement on the management of chronic hepatitis B | Chien R.-N.; JIA-HORNG KAO ; Peng C.-Y.; Chen C.-H.; CHUN-JEN LIU ; Huang Y.-H.; Hu T.-H.; Yang H.-I.; Lu S.-N.; YEN-HSUAN NI ; Chuang W.-L.; Lee C.-M.; Wu J.-C.; PEI-JER CHEN ; Liaw Y.-F. | Journal of the Formosan Medical Association | 50 | 47 | |
2003 | Technical quality of root canal treatment in Taiwan | Chueh L.-H.; Chen S.-C.; Lee C.-M.; Hsu Y.-Y.; Pai S.-F.; Kuo M.-L.; Chen C.-S.; Duh B.-R.; Yang S.-F.; Tung Y.-L.; CHUHSING KATE HSIAO | International Endodontic Journal | 48 | 40 | |
2003 | Telithromycin and quinupristin-dalfopristin resistance in clinical isolates of Streptococcus pyogenes: SMART program 2001 data | PO-REN HSUEH ; LEE-JENE TENG ; Lee C.-M.; Huang W.-K.; Wu T.-L.; Wan J.-H.; Yang D.; Shyr J.-M.; Chuang Y.-C.; Yan J.-J.; Lu J.-J.; Wu J.-J.; Ko W.-C.; Chang F.-Y.; Yang Y.-C.; Lau Y.-J.; Liu Y.-C.; Leu H.-S.; Liu C.-Y.; KWEN-TAY LUH | Antimicrobial Agents and Chemotherapy | 32 | 26 | |
2003 | Telithromycin- and fluoroquinolone-resistant Streptococcus pneumoniae in Taiwan with high prevalence of resistance to macrolides and β-lactams: SMART program 2001 data | PO-REN HSUEH ; LEE-JENE TENG ; Wu T.-L.; Yang D.; Huang W.-K.; Shyr J.-M.; Chuang Y.-C.; Wan J.-H.; Yan J.-J.; Lu J.-J.; Wu J.-J.; Ko W.-C.; Chang F.-Y.; Yang Y.-C.; Lau Y.-J.; Liu Y.-C.; Lee C.-M.; Leu H.-S.; Liu C.-Y.; KWEN-TAY LUH | Antimicrobial Agents and Chemotherapy | 36 | 34 | |
2008 | Transition from alcohol to other drugs among adolescents in Taiwan: The first drinking context matters | Chen C.-Y.; Tang G.-M.; Huang S.-L.; Lee C.-M.; Lew-Ting C.-Y.; CHUHSING KATE HSIAO ; DUAN-RUNG CHEN ; WEI J. CHEN | Journal of Studies on Alcohol and Drugs | 10 | 10 | |
2012 | Trends in susceptibility of vancomycin-resistant Enterococcus faecium to tigecycline, daptomycin, and linezolid and molecular epidemiology of the isolates: Results from the Tigecycline in Vitro Surveillance in Taiwan (TIST) study, 2006 to 2010 | Tsai H.-Y.; Liao C.-H.; Chen Y.-H.; Lu P.-L.; Huang C.-H.; Lu C.-T.; Chuang Y.-C.; Tsao S.-M.; Chen Y.-S.; Liu Y.-C.; Chen W.-Y.; Jang T.-N.; Lin H.-C.; Chen C.-M.; Shi Z.-Y.; SUNG-CHING PAN ; Yang J.-L.; HSIANG-CHI KUNG ; Liu C.-E.; Cheng Y.-J.; Liu J.-W.; Sun W.; Wang L.-S.; Ko W.-C.; Yu K.-W.; Chiang P.-C.; Lee M.-H.; Lee C.-M.; Hsu G.-J.; PO-REN HSUEH | Antimicrobial Agents and Chemotherapy | 20 | 19 | |
2013 | Trends in the antimicrobial susceptibilities and serotypes of Streptococcus pneumoniae: Results from the Tigecycline in Vitro Surveillance in Taiwan (TIST) study, 2006-2010 | Tsai H.-Y.; Chen Y.-H.; Liao C.-H.; Lu P.-L.; Huang C.-H.; Lu C.-T.; Chuang Y.-C.; Tsao S.-M.; Chen Y.-S.; Liu Y.-C.; Chen W.-Y.; Jang T.-N.; Lin H.-C.; Chen C.-M.; Shi Z.-Y.; SUNG-CHING PAN ; Yang J.-L.; HSIANG-CHI KUNG ; Liu C.-E.; Cheng Y.-J.; Liu J.-W.; Sun W.; Wang L.-S.; Ko W.-C.; Yu K.-W.; Chiang P.-C.; Lee M.-H.; Lee C.-M.; Hsu G.-J.; PO-REN HSUEH | International Journal of Antimicrobial Agents | 11 | 11 | |
2012 | Trends in the susceptibility of clinically important resistant bacteria to tigecycline: Results from the tigecycline In Vitro surveillance in Taiwan study, 2006 to 2010 | Chen Y.-H.; Lu P.-L.; Huang C.-H.; Liao C.-H.; Lu C.-T.; Chuang Y.-C.; Tsao S.-M.; Chen Y.-S.; Liu Y.-C.; Chen W.-Y.; Jang T.-N.; Lin H.-C.; Chen C.-M.; Shi Z.-Y.; SUNG-CHING PAN ; Yang J.-L.; HSIANG-CHI KUNG ; Liu C.-E.; Cheng Y.-J.; Liu J.-W.; Sun W.; Wang L.-S.; Ko W.-C.; Yu K.-W.; Chiang P.-C.; Lee M.-H.; Lee C.-M.; Hsu G.-J.; PO-REN HSUEH | Antimicrobial Agents and Chemotherapy | 39 | 35 | |
2014 | Trends in the susceptibility of methicillin-resistant Staphylococcus aureus to nine antimicrobial agents, including ceftobiprole, nemonoxacin, and tyrothricin: Results from the Tigecycline in Vitro Surveillance in Taiwan (TIST) study, 2006-2010 | Chen Y.-H.; Liu C.-Y.; Ko W.-C.; Liao C.-H.; Lu P.-L.; Huang C.-H.; Lu C.-T.; Chuang Y.-C.; Tsao S.-M.; Chen Y.-S.; Liu Y.-C.; Chen W.-Y.; Jang T.-N.; Lin H.-C.; Chen C.-M.; Shi Z.-Y.; SUNG-CHING PAN ; Yang J.-L.; HSIANG-CHI KUNG ; Liu C.-E.; Cheng Y.-J.; Liu J.-W.; Sun W.; Wang L.-S.; Yu K.-W.; Chiang P.-C.; Lee M.-H.; Lee C.-M.; Hsu G.-J.; PO-REN HSUEH | European Journal of Clinical Microbiology and Infectious Diseases | 22 | 19 | |
2017 | Ubiquitin ligase RNF138 promotes episodic ataxia type 2-associated aberrant degradation of human Cav2.1 (P/Q-type) calcium channels | Fu S.-J.; Jeng C.-J.; Ma C.-H.; Peng Y.-J.; Lee C.-M.; Fang Y.-C.; Lee Y.-C.; SUNG-CHUN TANG ; MENG-CHUN HU ; CHIH-YUNG TANG | 5 | 4 |